The Dow Jones Industrial Average (^DJI +1.79%) is up nearly 5% so far this year, with many of its best performers rising in value by 20% to 30%.
But some of the index's components haven't fared so well. Two well-known stocks in the DJIA have collapsed in value through the first six months of 2025. Investors on the lookout for bargains should take a closer look.
NYSE: CRM
Key Data Points
This tech giant is struggling in 2025
For years, Salesforce (CRM +0.51%) has been a market darling, consistently posting double-digit growth rates. Thus far in 2025, however, Salesforce stock has lost nearly one-quarter of its value. What's going on?
This fiscal year, Salesforce is anticipating 7% to 8% revenue growth -- its first single-digit annual growth rate in years. In past years, it has managed consistent 20% to 30% annual growth rates. Analysts are concerned that the company's best days are behind it. As an analyst at Bernstein Research concludes, "We have been concerned that Salesforce was a mature business in a mature market and that expectations were running too high in general.
Image source: Getty Images.
UnitedHealth stock is down 40%
It's been a very rough year for UnitedHealth Group (UNH +2.60%). Shares are down roughly 40% in value, with most of the drop occurring over the past 90 days alone. Is this your chance to buy a healthcare giant on the cheap?
This is a complicated and ongoing situation. Earnings forecasts have been reduced dramatically due to higher costs and claims, while the U.S. Department of Justice is investigating the company for overbilling. Meanwhile, the company's CEO departed in May, shortly after Wall Street analysts changed earnings projections.
UnitedHealth stock is cheap at just 12.2 times earnings. But investors need to get comfortable with all the moving pieces before jumping in.
